Vireo Health of Minnesota Appoints Amber Shimpa as Chief Executive Officer

Cross-organizational leader assumes new role following eight-year track record with Company –

– Founder Dr. Kyle Kingsley will maintain leadership position focused on key organizational priorities –

MINNEAPOLIS , Feb. 13, 2023 /PRNewswire/ -- Vireo Health of Minnesota , LLC ("Vireo" or the "Company"), a physician-founded medical cannabis company based in Minneapolis , today announced that Amber Shimpa has been appointed as Chief Executive Officer, effective immediately. Ms. Shimpa's appointment to the role follows eight years of cross-organizational leadership at the Company, including serving as the Company's first Chief Financial Officer when it began operating under the name Minnesota Medical Solutions.

Amber Shimpa commented, "I'm proud to join Kyle in this new role and lead Vireo into the future. I look forward to working more closely with our team members and partner organizations to improve the lives of patients and other Minnesotans who have been negatively impacted by the failed war on drugs. Our organization has been steadfast in its commitment to these initiatives since our inception, and we'll continue to do this important work despite significant challenges posed by current federal regulations and related capital constraints."

Vireo Health of Minnesota was founded in 2014 by former Hennepin County Medical Center emergency room physician, Dr. Kyle Kingsley , after learning about the medical benefits of cannabis for patients with chronic pain. Dr. Kingsley will remain actively involved with the Company and continue to support Ms. Shimpa on matters related to public affairs, product quality, and as an advocate for safe and affordable access to cannabis for Minnesotans.

Dr. Kingsley commented, "Amber has been an incredible advisor and business partner to me since our formation. Her tireless work to advance our mission has earned the respect of our entire organization, and she personifies the essence of the professional talent, growth mindset and integrity that cannabis companies should bring to the communities in which they operate. She has become an irreplaceable executive unique in her compassion for her team and her community, and I'm confident her enhanced role will serve our Company well."

Vireo Health of Minnesota began serving medical cannabis products to Minnesota patients in 2015. Since then, the Company has grown to serve over 46,000 patients with more than 200 Minnesota -based employees. In addition to its work serving medical patients, the Company funds restorative justice programming through its ongoing criminal expungement clinics, community educational events, and direct fundraising campaigns for The Last Prisoner Project and its 1937 Impact Fund. The Company's medical and scientific research teams also continue to work collaboratively with the University of Minnesota , Health Partners and Park Nicollet to study the impacts of medical cannabis on cancer patients and adults with chronic pain.

About Vireo Health of Minnesota , LLC

Vireo Health of Minnesota , LLC, a subsidiary of Goodness Growth Holdings, Inc. (CSE: GDNS; OTCQX: GDNSF), is a physician-founded medical cannabis company based in Minneapolis . The Company's mission is to provide safe access, quality products and value to its patients while supporting its local communities through active participation and restorative justice programs. Vireo Health of Minnesota manufactures proprietary, branded cannabis products which it distributes through its network of eight Green Goods® retail dispensaries throughout Minnesota . For more information about Vireo Health, please visit www.vireohealth.com .

Media Inquiries:
Amanda Hutcheson
Senior Manager, Communications
amandahutcheson@vireohealth.com
(919) 815-1476

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/vireo-health-of-minnesota-appoints-amber-shimpa-as-chief-executive-officer-301745651.html

SOURCE Vireo Health International, Inc.

News Provided by PR Newswire via QuoteMedia

CNX:GDNS,GDNSF
The Conversation (0)
Cannabis business with marijuana leaves and stock

Cannabis Market 2025 Year-End Review

2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
Cannabis plant with green leaves and buds on a dark green background.

Cannabis Market Forecast: Top Trends for Cannabis in 2026

The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...

Interactive Chart

Latest Press Releases

Related News